Stock UniverseDerived research view · source repositories remain read-only

Bio-Rad Laboratories, Inc. (BIO)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Qualified
Selection Score
38.16
Global Rank
670
Market Cap
7.52B
Latest Close
294.32
RS Composite
-2.52% · G#1553

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
13.63%
3M
9.07%
6M
-8.12%
1Y
32.55%
3Y
-21.17%
5Y
-51.14%
10Y
97.73%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 340.94K · 30-day average: 459.07K · Max drawdown over stored range: -73.77%

Research Snapshot

Relative Strength vs SPX

RS Composite-2.52%
20D RS13.74%
60D RS0.08%
120D RS-13.25%
Global RS Rank1553 · 53.71% percentile
Qualified+ RS Rank557 · 55.72% percentile
Group ScopeQualified+
Primary RS Rank48 · 66.20% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank55 / 246
Primary Percentile78.05
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-302.59B1.34B57.60M168.80M6.24886.70M267.70M619.00M27M51.87%2.22%6.52%34.24%23.90%1.56B802.90M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$6.2447.1x$95.813.1x$22.9012.9x$32.809.0x

Shares Diluted: 27M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2922.5452802.22671.22566.52583.2
Revenue Growth (YoY)14.807%-4.118%-4.675%-3.92%0.651%
Gross Profit1663.0961567.31430.81393.71343.6
Operating Income564.736482.6365.7290.8266.1
Free Cash Flow535.75481.6218.2289.6374.6
Free Cash Flow Per Share17.7362.747.4710.26413.731
EPS (Diluted) GAAP140.83-121.79-21.82-65.36471227.85
EPS Growth11.354%10200%10200%10200%10200%
EPS Non-GAAP
Gross Margin56.906%55.931%53.564%54.304%52.013%
Operating Margin19.323%17.222%13.69%11.331%10.301%
Profit Margin145.567%-129.452%-23.858%-71.857%29.417%
Free Cash Flow Margin18.332%2.912%8.169%11.284%14.501%
Shares Outstanding (Diluted)30.20829.78529.20928.21427.281
Shares Change (YoY)0.159%-1.4%-1.934%-3.406%-3.307%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-30592.10M52.25%34.10M5.76%-527.10M-89.02%-19.5526.96M1.56B802.90Mprocessed
2025 Q42026-02-13693.20M49.80%-118.90M-17.15%720.00M1.04%26.6527.02M1.54B1.20Bprocessed
2025 Q32025-10-29653.00M52.59%65.30M10.00%-341.90M-52.36%-12.7026.92M1.42B1.20Bprocessed
2025 Q22025-07-31651.60M52.99%77.10M11.83%317.80M48.77%11.6727.23M1.37B1.20Bprocessed
2025 Q12025-05-01585.40M52.27%23.70M4.05%64.00M10.93%2.2927.95M1.66B1.20Bprocessed
2024 Q42025-02-14667.48M51.22%58.33M8.74%-715.80M-1.07%-25.5728.00M1.66B1.20Bprocessed
2024 Q32024-10-31649.73M54.78%64.47M9.92%653.17M1.01%23.3427.98M1.62B1.20Bprocessed
2024 Q22024-08-02638.48M55.62%101.50M15.90%-2.17B-3.39%-76.2628.39M1.62B1.20Bprocessed
2024 Q12024-05-08610.82M53.37%44.71M7.32%383.92M62.85%13.4528.54M1.65B1.20Bprocessed
2023 Q42024-02-16681.22M53.78%95.32M13.99%349.71M51.34%12.1528.79M1.61B1.20Bprocessed
2023 Q32023-10-27632.12M53.10%90.95M14.39%106.26M16.81%3.6429.22M1.76B1.20Bprocessed
2023 Q22023-08-04681.11M53.22%89.62M13.16%-1.16B-1.71%n/a29.36M1.72B1.20Bprocessed
2023 Q12023-05-05676.84M53.55%61.91M9.15%68.96M10.19%2.3229.75M1.85B1.20Bprocessed
2022 Q42023-02-17730.24M53.95%126.18M17.28%833.49M1.14%28.0829.68M1.79B1.19Bprocessed
2022 Q32022-10-28680.80M54.90%92.80M13.63%-164.23M-24.12%-5.5229.73M1.85B1.20Bprocessed
2022 Q22022-07-29691.10M57.30%120.22M17.40%-927.18M-1.34%-31.1229.79M1.97B1.20Bprocessed
2022 Q12022-04-29700.06M57.65%143.42M20.49%-3.37B-4.81%-112.5729.93M2.07B1.20Bprocessed
2021 Q42022-02-11732.72M54.73%106.98M14.60%-1.57B-2.15%-52.0030.26M869.92Mn/aprocessed
2021 Q32021-10-29747.05M58.56%156.80M20.99%3.93B5.26%129.9630.22M1.34B10.64Mprocessed
2021 Q22021-07-30715.93M56.09%124.78M17.43%914.11M1.28%30.3230.15M1.16B10.78Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.